iRhythm Technologies (IRTC) Stock Price, News & Analysis

Company Overview

iRhythm Technologies, Inc. is a digital health care company focused on ambulatory cardiac monitoring and the diagnosis of cardiac arrhythmias. The company combines wearable biosensor technology, cloud-based data analysis and clinical services to help physicians detect and manage irregular heart rhythms, including atrial fibrillation.

Its principal products include the Zio monitor portfolio, which is designed for extended, continuous electrocardiogram monitoring in an easy-to-use wearable format. iRhythm’s platform collects cardiac data outside the traditional clinical setting and uses proprietary algorithms and analysis tools to identify potentially significant events for review by health care professionals. The company also provides reporting and related support services that assist clinicians in interpreting monitoring results and making treatment decisions.

Founded in 2006 and headquartered in San Francisco, iRhythm primarily serves health care providers and patients in the United States. The company has also expanded availability of its technology and services into select international markets, including the United Kingdom. iRhythm’s products are used across cardiology, primary care and other clinical settings where extended monitoring can support the evaluation of suspected or previously undiagnosed arrhythmias.

Key Stats

• Today's Range: $106.77 to $111.37
• 50-Day Range: $109.09 to $128.52
• 52-Week Range: $100.85 to $212.00
• Volume: 626,265 shs
• Average Volume: 514,582 shs
• Market Capitalization: $3.60 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $180.07
• Consensus Rating: Moderate Buy

iRhythm Technologies Stock Analysis - MarketRank™

iRhythm Technologies scored higher than 69% of companies evaluated by MarketBeat, and ranked 216th out of 888 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.5 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

iRhythm Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.94, and is based on 2 strong buy ratings, 12 buy ratings, 1 hold rating, and 1 sell rating.

Upside Potential

iRhythm Technologies has a consensus price target of $180.07, representing about 65.1% upside from its current price of $109.09.

Amount of Analyst Coverage

iRhythm Technologies has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 141.67%

Earnings Growth

Earnings for iRhythm Technologies are expected to grow by 141.67% in the coming year, from $0.60 to $1.45 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of iRhythm Technologies is -253.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of iRhythm Technologies is -253.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

iRhythm Technologies has a P/B Ratio of 23.01. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

9.36% of the float of iRhythm Technologies has been sold short.

Short Interest Ratio / Days to Cover

iRhythm Technologies has a short interest ratio ("days to cover") of 5.56.

Change versus previous month

Short interest in iRhythm Technologies has recently increased by 9.56%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

iRhythm Technologies does not currently pay a dividend.

Dividend Growth

iRhythm Technologies does not have a long track record of dividend growth.

News and Social Media

• Score: 2.6 / 5
• News Sentiment: 0.20

News Sentiment

iRhythm Technologies has a news sentiment score of 0.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.43 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 10 news articles for iRhythm Technologies this week, compared to 5 articles on an average week.

MarketBeat Follows

1 people have added iRhythm Technologies to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, iRhythm Technologies insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.98% of the stock of iRhythm Technologies is held by insiders.

Percentage Held by Institutions

iRhythm Technologies has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/06/2026
• Today: 10/05/2026
• Next Earnings (Estimated): 10/29/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:IRTC
• CIK: 1388658
• Web: www.irhythmtech.com
• Phone: (415) 632-5700
• Fax: N/A
• Employees: 2,400
• Year Founded: 2006

Price Target and Rating

• Average Price Target for iRhythm Technologies: $180.07
• High Price Target: $220.00
• Low Price Target: $147.00
• Potential Upside/Downside: +65.1%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.94
• Research Coverage: 16 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.43)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 181.82
• P/E Growth: N/A
• Net Income: -$44.55 million
• Net Margins: -1.69%
• Pretax Margin: -1.57%
• Return on Equity: 10.11%
• Return on Assets: 1.53%

Debt

• Debt-to-Equity Ratio: 3.50
• Current Ratio: 3.86
• Quick Ratio: 3.74

Sales & Book Value

• Annual Sales: $747.14 million
• Price / Sales: 4.81
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $4.74 per share
• Price / Book: 23.01

Miscellaneous

• Outstanding Shares: 32,960,000
• Free Float: 32,640,000
• Market Cap: $3.60 billion
• Optionable: Optionable
• Beta: 1.45